1. Home
  2. RLMD vs WFCF Comparison

RLMD vs WFCF Comparison

Compare RLMD & WFCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • WFCF
  • Stock Information
  • Founded
  • RLMD 2004
  • WFCF 1996
  • Country
  • RLMD United States
  • WFCF United States
  • Employees
  • RLMD N/A
  • WFCF N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • WFCF Computer Software: Prepackaged Software
  • Sector
  • RLMD Health Care
  • WFCF Technology
  • Exchange
  • RLMD Nasdaq
  • WFCF Nasdaq
  • Market Cap
  • RLMD 53.4M
  • WFCF 59.1M
  • IPO Year
  • RLMD N/A
  • WFCF 2011
  • Fundamental
  • Price
  • RLMD $1.59
  • WFCF $12.45
  • Analyst Decision
  • RLMD Buy
  • WFCF
  • Analyst Count
  • RLMD 3
  • WFCF 0
  • Target Price
  • RLMD $5.00
  • WFCF N/A
  • AVG Volume (30 Days)
  • RLMD 1.6M
  • WFCF 4.2K
  • Earning Date
  • RLMD 11-06-2025
  • WFCF 11-11-2025
  • Dividend Yield
  • RLMD N/A
  • WFCF N/A
  • EPS Growth
  • RLMD N/A
  • WFCF N/A
  • EPS
  • RLMD N/A
  • WFCF 0.39
  • Revenue
  • RLMD N/A
  • WFCF $25,604,000.00
  • Revenue This Year
  • RLMD N/A
  • WFCF N/A
  • Revenue Next Year
  • RLMD N/A
  • WFCF N/A
  • P/E Ratio
  • RLMD N/A
  • WFCF $31.75
  • Revenue Growth
  • RLMD N/A
  • WFCF N/A
  • 52 Week Low
  • RLMD $0.24
  • WFCF $9.26
  • 52 Week High
  • RLMD $3.98
  • WFCF $13.50
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 74.57
  • WFCF 67.79
  • Support Level
  • RLMD $1.44
  • WFCF $12.26
  • Resistance Level
  • RLMD $1.72
  • WFCF $12.67
  • Average True Range (ATR)
  • RLMD 0.24
  • WFCF 0.21
  • MACD
  • RLMD 0.05
  • WFCF 0.03
  • Stochastic Oscillator
  • RLMD 86.90
  • WFCF 75.40

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

Share on Social Networks: